Showing 2271-2280 of 8826 results for "".
The Big Idea: Jeanine Downie, MD on Practice Planning
https://practicaldermatology.com/topics/practice-management/the-big-idea-jeanine-downie-md-on-practice-planning/19279/Dr. Downie discusses the benefits of a defined benefits pension plan and why she incorporated it into her practice plan from the start. Featured in "What's The Big Idea."CoolSculpting Circumferential Treatment Video
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/coolsculpting-circumferential-treatment-video/19442/Dr. Brian Zelickson of Edina, MN is demonstrating on a patient the benefits of using a circumferential treatment method with CoolSculpting for maximum results. Dr. Zelickson details the benefits of this type of treatment and the results his patient received.DWTV Extra: Remembering Dr. Robert Sidbury
https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-remembering-dr-robert-sidbury/36520/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD; Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD; and Board Member Peter A. Lio, MD, FAAD, reflect on the life and career of their colleague Robert Sidbury, MD, MPH, who passed away suddenly at the age of 61.Considerations for the Use of Biologics in Children with Atopic Dermatitis
https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37152/Dawn Zhang Eichenfield, MD, PhD, a dermatologist at Rady Children's Hospital-San Diego and an assistant clinical professor of dermatology at the University of California, San Diego, School of Medicine, explains the most important factors to understand when prescribing biologics for pediatric atopicISDPA: Dr. Dy on JAK Inhibitors for Alopecia Areata
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-dy-jak-inhibitors-alopecia-areata/29150/Lady Dy, MD, talks about the efficacy and safety of JAK inhibitors for treating alopecia areata at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.ISDPA: Dr. Bhatia and Dr. Zirwas Discuss the Itchy Patient
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-bhatia-and-dr-zirwas-discuss-itchy-patient/27065/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, talks with Matthew Zirwas, MD, about Dr. Zirwas’s lecture on the itchy patient and the latest solutions for itch at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.Rosacea and Beyond: PDT Patient Success Stories
https://practicaldermatology.com/topics/skin-cancer-photoprotection/rosacea-and-beyond-pdt-patient-success-stories/20214/Dr. Jill S. Waibel, a Miami dermatologist specializing in laser surgery, cosmetic dermatology, and medical dermatology, shares success stories using photodynamic therapy (PDT) and provides techniques and tips for optimal patient results. Dr. Waibel is a world-recognized leader and innovator in dermaReducing Atopic March Risk in Pediatric Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/reducing-atopic-march-risk-in-pediatric-atopic-dermatitis/54821/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, is joined by Editorial Board member Peter Lio, MD, to analyze the Journal of the American Academy of Dermatology article "Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus cClinical Data on Switching to Upadacitinib
https://practicaldermatology.com/series/updates-atopic-dermatitis/clinical-data-on-switching-to-upadacitinib/36534/Clinical investigator Christopher Bunick, MD, PhD, discusses results from the LEVEL UP trial among patients who switched from dupilumab to upadacitinib for atopic dermatitis.Significant FDA Approval for PDT
https://practicaldermatology.com/series/pdt-in-practice/significant-fda-approval-pdt/29102/Dr. Jonathan S. Weiss discusses the importance of a recent FDA approval involving dosing of a PDT photosensitizer for both lesion-directed and field-directed treatment of actinic keratosis.